On the basis of a large number of reports concerning the detection of lipid peroxidation products as biomarkers in human diseases, there is no doubt that their steady-state levels increase under pathophysiological states associated with oxidative stress. The key question is whether they play any causative roles. This may be a matter of primary concern, which represents an important direction to pursue in the future of toxicology. My latest approach from autoimmune response induced by lipid peroxidation products will be illustrated.
No takes yet. Share an insight, caveat, or question.
Kôji Uchida (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: